BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 23447004)

  • 21. Diabetes, pre-diabetes and associated risks on Minnesota code-indicated major electrocardiogram abnormality among Chinese: a cross-sectional diabetic study in Fujian province, southeast China.
    Lin L; Chen G; Zou X; Zhao J; Zhu F; Tu M; Xu S; Lin W; Yang S; Zhang Y; Lin M; Chen N; Huang H; Liang J; Li L; Yao J
    Obes Rev; 2009 Jul; 10(4):420-30. PubMed ID: 19460110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of postpartum carbohydrate intolerance and cardiovascular risk factors in women with gestational diabetes.
    Akinci B; Celtik A; Genc S; Yener S; Demir T; Secil M; Kebapcilar L; Yesil S
    Gynecol Endocrinol; 2011 May; 27(5):361-7. PubMed ID: 20540676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microalbuminuria, cardiovascular risk factors, and insulin resistance in two populations with a high risk of type 2 diabetes mellitus.
    Hodge AM; Dowse GK; Zimmet PZ
    Diabet Med; 1996 May; 13(5):441-9. PubMed ID: 8737026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevalence of the glucose metabolism disturbances in screening of adult inhabitants of Krakow].
    Szurkowska M; Szafraniec K; Gilis-Januszewska A; Pach D; Krzentowska A; Szybiński Z; Huszno B
    Przegl Lek; 2006; 63(9):728-32. PubMed ID: 17479858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fasting plasma glucose (FPG) and the risk of impaired glucose tolerance in obese children and adolescents.
    Maffeis C; Pinelli L; Brambilla P; Banzato C; Valzolgher L; Ulmi D; Di Candia S; Cammarata B; Morandi A
    Obesity (Silver Spring); 2010 Jul; 18(7):1437-42. PubMed ID: 19851301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type 2 diabetes mellitus: a high-risk condition for cardiovascular disease irrespective of the different degrees of obesity.
    Song SH; Hardisty CA
    QJM; 2008 Nov; 101(11):875-9. PubMed ID: 18776208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiopoietin-2 levels in glucose intolerance, hypertension, and metabolic syndrome in Asian Indians (Chennai Urban Rural Epidemiology Study-74).
    Anuradha S; Mohan V; Gokulakrishnan K; Dixit M
    Metabolism; 2010 Jun; 59(6):774-9. PubMed ID: 19913849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
    Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
    J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III).
    Muntner P; He J; Chen J; Fonseca V; Whelton PK
    Ann Epidemiol; 2004 Oct; 14(9):686-95. PubMed ID: 15380800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin resistance is the best predictor of the metabolic syndrome in subjects with a first-degree relative with type 2 diabetes.
    Utzschneider KM; Van de Lagemaat A; Faulenbach MV; Goedecke JH; Carr DB; Boyko EJ; Fujimoto WY; Kahn SE
    Obesity (Silver Spring); 2010 Sep; 18(9):1781-7. PubMed ID: 20379148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
    da Silva RC; Miranda WL; Chacra AR; Dib SA
    J Diabetes Complications; 2007; 21(2):84-92. PubMed ID: 17331856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and characteristics of impaired glucose metabolism in patients referred to comprehensive cardiac rehabilitation: the DANSUK study.
    Boas Soja AM; Zwisler AD; Melchior T; Hommel E; Torp-Pedersen C; Madsen M
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):784-90. PubMed ID: 17001219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risks for type-2 diabetes associated with the metabolic syndrome and the interaction between impaired fasting glucose and other components of metabolic syndrome the study from Jiangsu, China of 5 years follow-up.
    Liu SJ; Guo ZR; Hu XS; Wu M; Chen FM; Kang GD; Zhou H; Guo L
    Diabetes Res Clin Pract; 2008 Jul; 81(1):117-23. PubMed ID: 18485514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
    Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
    Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type 2 diabetes mellitus and impaired glucose regulation in overweight and obese children and adolescents living in Serbia.
    Vukovic R; Mitrovic K; Milenkovic T; Todorovic S; Zdravkovic D
    Int J Obes (Lond); 2012 Nov; 36(11):1479-81. PubMed ID: 22270379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of metabolic syndrome and insulin resistance in overweight and obese women according to the different diagnostic criteria.
    Kocełak P; Chudek J; Olszanecka-Glinianowicz M
    Minerva Endocrinol; 2012 Sep; 37(3):247-54. PubMed ID: 22766891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin resistance and impaired glucose tolerance in overweight and obese Costa Rican schoolchildren.
    Holst-Schumacher I; Nuñez-Rivas H; Monge-Rojas R; Barrantes-Santamaría M
    Food Nutr Bull; 2008 Jun; 29(2):123-31. PubMed ID: 18693476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of cardiovascular disease and risk factors in a type 2 diabetic population of the North Catalonia diabetes study.
    Jurado J; Ybarra J; Solanas P; Caula J; Gich I; Pou JM; Romeo JH
    J Am Acad Nurse Pract; 2009 Mar; 21(3):140-8. PubMed ID: 19302689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease.
    Meigs JB; Wilson PW; Fox CS; Vasan RS; Nathan DM; Sullivan LM; D'Agostino RB
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2906-12. PubMed ID: 16735483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening among male industrial workers in India shows high prevalence of impaired glucose tolerance, undetected diabetes and cardiovascular risk clustering.
    Jagannathan R; Nanditha A; Sundaram S; Simon M; Shetty AS; Snehalatha C; Johnston DG; Ramachandran A
    J Assoc Physicians India; 2014 Apr; 62(4):312-5. PubMed ID: 25327033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.